CombiMatrix to Present at Upcoming Investor Conferences IRVINE, Calif., May 22, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...

CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results Achieves record reproductive health revenues on higher test volumes and average revenue per test, expands gross margin, significantly narrows operating loss and reports record cash collections ...

CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017 IRVINE, Calif., April 27, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...